
Breast CT developer Koning has raised over $2.6 million in its first crowdfunding campaign.
Conducted on crowdfunding platform Republic, the campaign was completed in five months and exceeded the firm's capital targets, Koning said.
In other news, a trial is now underway to assess the company's breast CT scanner in screening applications. Clinics in Daytona Beach, FL, and Knoxville, TN, are currently participating in the trial, which will be used to support a submission to the U.S. Food and Drug Administration for use of the technology in screening applications.
Koning also reported that it should be ready to begin accepting new installation requests for systems in the latter part of 2022. In addition, several new contracts are underway for devices that are expected to be deployed in major U.S. cities in the second and third quarters of 2022, according to the firm.














![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)





